Published in
Lippincott, Williams & Wilkins, Neurology: Neuroimmunology and Neuroinflammation, 5(2), p. e144, 2015
DOI: 10.1212/nxi.0000000000000144
Links
- ORCID
- Lippincott, Williams & Wilkins
- [archive-ouverte.unige.ch]
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net] | PDF
Tools
Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS
Journal article published in 2015 by
Maria Zimmermann,
Nicholas S. R. Sanderson 
,
Maria Rasenack,
Patrice H. Lalive,
Alois B. Lang,
Francois Curtin,
Raija L. P. Lindberg,
Ludwig Kappos,
Tobias Derfuss
,
Maria Rasenack,
Patrice H. Lalive,
Alois B. Lang,
Francois Curtin,
Raija L. P. Lindberg,
Ludwig Kappos,
Tobias Derfuss
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
To monitor the systemic immune responses of patients with multiple sclerosis (MS) under treatment with GNbAC1, a monoclonal antibody against the envelope protein of the MS- associated retrovirus, during a phase 2a trial.